Back to search

Article

2’, 3’, 4’-Trihydroxychalcone Changes Estrogen Receptor Α Regulation of Genes and Breast Cancer Cell Proliferation by a Reprogramming Mechanism

2021-09-27

Abstract excerpt

<title>Abstract</title> <p>BackgroundMenopausal hormone therapy (MHT) is recommended for only five years to treat vasomotor symptoms and vulvovaginal atrophy because of safety issues with long-term treatment. We examined the ability of 2’, 3’, 4’-trihydroxychalcone (2’, 3’, 4’-THC) to modulate ERα-mediated responses on gene regulation and cell proliferation to identify drugs that can potentially overcome the adve...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5429412c-4aaa-579e-9fee-8abe71a82282
DOI
10.21203/rs.3.rs-927121/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
2’, 3’, 4’-Trihydroxychalcone Changes Estrogen Receptor Α Regulation of Genes and Breast Cancer Cell Proliferation by a Reprogramming MechanismDOI 10.21203/rs.3.rs-927121/v1
Select a neighboring publication to make it the new centre.